Literature DB >> 11770706

Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance.

S Stolnik1, C R Heald, J Neal, M C Garnett, S S Davis, L Illum, S C Purkis, R J Barlow, P R Gellert.   

Abstract

The micellar-like particle systems produced from poly-D,L-lactide-poly(ethylene glycol) (PLA-PEG) copolymers have been assessed using a range of physicochemical characterisation methods, followed by in vivo studies of their biodistribution after intravenous administration to the rat. The size of the PEG chain was kept constant at 5 or 2 kDa, while the PLA size increased within a series from 2 to 25 kDa. The results obtained reveal, that in an aqueous medium the copolymers assembled into micellar-like structures, with the PLA segments forming the core and the PEG segments the surrounding corona. The size of the PLA segments dominated the process of assembly of the molecules and the characteristics of the resultant micellar-like particles. The PLA-PEG micellar particles were found to be less dynamic than those obtained from conventional surfactants. Particles formed from the lower molecular weight PLA polymers allowed a level of chain mobility while the cores of the micellar particles formed from higher molecular weight PLA appeared to be solid-like in nature. The size of the micellar particles was dependent on the copolymer molecular weight and the z-average diameter increased from 25 to 76 nm as the molecular weight of the PLA moiety increased. This provides an ability to control the particle size by adjusting the molecular weight of the PLA moiety. Following intravenous administration to the rat model, micellar-like particles smaller than approximately 70 nm accumulated in the liver, despite the fact that the PEG corona provided an effective steric stabilization effect. Micellar-like particles with a diameter of more than approximately 70 nm exhibited prolonged systemic circulation and reduced liver uptake, although the steric stabilisation of these particles was shown to be less effective. These findings agree with recent observations from other research groups; that indicate a possibility that very small particulates can pass through the sinusoidal fenestrations in the liver and gain access to the parenchymal cells of the liver.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770706     DOI: 10.3109/10611860108998772

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  12 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

2.  Drug-Polymer Interaction, Pharmacokinetics and Antitumor Effect of PEG-PLA/Taxane Derivative TM-2 Micelles for Intravenous Drug Delivery.

Authors:  Qiao Wang; Yi Liu; Chenguang Pu; Hongjuan Zhang; Xinyi Tan; Jingxin Gou; Haibing He; Tian Yin; Yu Zhang; Yanjiao Wang; Xing Tang
Journal:  Pharm Res       Date:  2018-09-13       Impact factor: 4.200

3.  Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.

Authors:  Athulya Aravind; Yasuhiko Yoshida; Toru Maekawa; D Sakthi Kumar
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

4.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.

Authors:  Jianjun Cheng; Benjamin A Teply; Ines Sherifi; Josephine Sung; Gaurav Luther; Frank X Gu; Etgar Levy-Nissenbaum; Aleksandar F Radovic-Moreno; Robert Langer; Omid C Farokhzad
Journal:  Biomaterials       Date:  2006-10-20       Impact factor: 12.479

5.  Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.

Authors:  Shanta Dhar; Frank X Gu; Robert Langer; Omid C Farokhzad; Stephen J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-31       Impact factor: 11.205

6.  Biodegradable nanoparticles of methoxy poly(ethylene glycol)-b-poly( d, l-lactide)/methoxy poly(ethylene glycol)- b-poly(ϵ-caprolactone) blends for drug delivery.

Authors:  Yodthong Baimark; Yaowalak Srisuwan
Journal:  Nanoscale Res Lett       Date:  2012-05-30       Impact factor: 4.703

7.  Pegylation of poly(γ-benzyl-L-glutamate) nanoparticles is efficient for avoiding mononuclear phagocyte system capture in rats.

Authors:  Ipek Ozcan; Freimar Segura-Sánchez; Kawthar Bouchemal; Murat Sezak; Ozgen Ozer; Tamer Güneri; Gilles Ponchel
Journal:  Int J Nanomedicine       Date:  2010-12-08

8.  Toxicity of PEG-Coated CoFe2O4 Nanoparticles with Treatment Effect of Curcumin.

Authors:  Shahnaz Akhtar; Wenzhen An; Xiaoying Niu; Kang Li; Shahzad Anwar; Khan Maaz; Muhammad Maqbool; Lan Gao
Journal:  Nanoscale Res Lett       Date:  2018-02-14       Impact factor: 4.703

9.  Atomic-level characterization and cilostazol affinity of poly(lactic acid) nanoparticles conjugated with differentially charged hydrophilic molecules.

Authors:  María Francisca Matus; Martín Ludueña; Cristian Vilos; Iván Palomo; Marcelo M Mariscal
Journal:  Beilstein J Nanotechnol       Date:  2018-05-02       Impact factor: 3.649

10.  pH-sensitive and folic acid-targeted MPEG-PHIS/FA-PEG-VE mixed micelles for the delivery of PTX-VE and their antitumor activity.

Authors:  Yan Di; Ting Li; Zhihong Zhu; Fen Chen; Lianqun Jia; Wenbing Liu; Xiumei Gai; Yingying Wang; Weisan Pan; Xinggang Yang
Journal:  Int J Nanomedicine       Date:  2017-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.